1. Home
  2. Labeler Index
  3. Eli Lilly And Company
  4. 0002-7717
  5. NDC Package Code: 0002-7717-61 Omvoh

NDC Package 0002-7717-61 Omvoh

Mirikizumab-mrkz Kit Subcutaneous; Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0002-7717-61
Package Description:
1 KIT in 1 CARTON * 1 mL in 1 SYRINGE * 2 mL in 1 SYRINGE * 1 mL in 1 SYRINGE (0002-8011-01) * 2 mL in 1 SYRINGE (0002-3116-01)
Product Code:
0002-7717
Proprietary Name:
Omvoh
Non-Proprietary Name:
Mirikizumab-mrkz
Usage Information:
OMVOH is contraindicated in patients with a history of serious hypersensitivity reaction to mirikizumab-mrkz or any of the excipients [see Warnings and Precautions (5.1)].
11-Digit NDC Billing Format:
00002771761
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Eli Lilly And Company
Dosage Form:
Kit - A packaged collection of related material.
Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Sample Package:
Yes
FDA Application Number:
BLA761279
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
01-15-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
0002-7717-111 KIT in 1 CARTON * 1 mL in 1 SYRINGE * 2 mL in 1 SYRINGE * 1 mL in 1 SYRINGE (0002-8011-01) * 2 mL in 1 SYRINGE (0002-3116-01)

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0002-7717-61?

The NDC Packaged Code 0002-7717-61 is assigned to a package of 1 kit in 1 carton * 1 ml in 1 syringe * 2 ml in 1 syringe * 1 ml in 1 syringe (0002-8011-01) * 2 ml in 1 syringe (0002-3116-01) of Omvoh, a human prescription drug labeled by Eli Lilly And Company. The product's dosage form is kit and is administered via subcutaneous; subcutaneous form.

Is NDC 0002-7717 included in the NDC Directory?

Yes, Omvoh with product code 0002-7717 is active and included in the NDC Directory. The product was first marketed by Eli Lilly And Company on January 15, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 0002-7717-61?

The 11-digit format is 00002771761. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20002-7717-615-4-200002-7717-61